zopimac 2 oral tablet
macleods pharmaceuticals limited, india - eszopiclone - oral tablet - 2
dolutegravir 50 mg, lamivudine 300 mg and tenofovir disoproxil fumarate 300 mg tablet oral tablet dolutegravir 50mg, lamivudine 300mg and tenofovir disoproxil fumerate 300mg
macleods pharmaceuticals limited, india - dolutegravir sodium, lamivudine , tenofovovir disoproxil fumarate - oral tablet - dolutegravir 50mg, lamivudine 300mg and tenofovir disoproxil fumerate 300mg
methimazole tablet
macleods pharmaceuticals limited - methimazole (unii: 554z48xn5e) (methimazole - unii:554z48xn5e) - methimazole is indicated: - in patients with graves’ disease with hyperthyroidism or toxic multinodular goiter for whom surgery or radioactive iodine therapy is not an appropriate treatment option - to ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy. methimazole is contraindicated in the presence of hypersensitivity to the drug or any of the other product components.
entacapone tablet
macleods pharmaceuticals limited - entacapone (unii: 4975g9nm6t) (entacapone - unii:4975g9nm6t) - entacapone 200 mg - entacapone tablets are indicated as an adjunct to levodopa and carbidopa to treat end-of-dose “wearing-off” in patients with parkinson’s disease (see clinical pharmacology, clinical studies). entacapone tablets effectiveness has not been systematically evaluated in patients with parkinson’s disease who do not experience end-of-dose “wearing-off”. entacapone tablets are contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. entacapone tablets are not a controlled substance. animal studies to evaluate the drug abuse and potential dependence have not been conducted. although clinical studies have not revealed any evidence of the potential for abuse, tolerance or physical dependence, systematic studies in humans designed to evaluate these effects have not been performed.
metformin hydrochloride tablet, film coated
macleods pharmaceuticals limited - metformin hydrochloride (unii: 786z46389e) (metformin - unii:9100l32l2n) - metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults and children with type 2 diabetes mellitus. metformin hydrochloride tablets are contraindicated in patients with: • severe renal impairment (egfr below 30 ml/min/1.73 m2 ) (see warnings and precautions ). • known hypersensitivity to metformin hydrochloride. • acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. diabetic ketoacidosis should be treated with insulin.
tolterodine tartrate tablet, film coated
macleods pharmaceuticals limited - tolterodine tartrate (unii: 5t619tqr3r) (tolterodine - unii:whe7a56u7k) - tolterodine tartrate 1 mg - tolterodine tartrate tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. tolterodine tartrate tablets are contraindicated in patients with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma. tolterodine tartrate is also contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients, or to fesoterodine fumarate extended-release tablets which, like tolterodine tartrate, are metabolized to 5-hydroxymethyl tolterodine.
carbimazole macleods tablet
macleods pharmaceuticals ltd., india - carbimazole - tablet - 5 mg
kanamac powder for solution for injection 1g
macleods pharmaceuticals limited, india - kanamycin - powder for solution for injection - 1g
levomac 500 tablets 500mg
macleods pharmaceuticals limited, india - levofloxacin - tablets - 500mg
chloramphenicol powder for solution for injection 1
macleods pharmaceuticals limited, india - chloramphenicol sodium succinate - powder for solution for injection - 1